METROPOLIS HEALTHCARE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,850 INR | +0.77% |
|
+4.87% | +10.26% |
| May. 10 | India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand | RE |
| Apr. 11 | Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue | MT |
Evolution of the average Target Price on Metropolis Healthcare Limited
Price target over the last 5 years
History of analyst recommendation changes
b2b732da7e439a2c7f1fe0390.uIlT2X_4eft9JDuO-q6I5ButKI3KLgkSDaxkmXQLaQQ.8-McrD2LPo4ZVGTWrczHkk3CUvqjVj5VSJUoygxyBlCA0WGvEZ8wyRsJag~f0cca64ebb224acb44f16372bc07c6d1
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
1,850
INR
Average target price
1,733
INR
Spread / Average Target
-6.35%
High Price Target
2,200
INR
Spread / Highest target
+18.90%
Low Price Target
1,341
INR
Spread / Lowest Target
-27.52%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B+
EPS Revisions
- Stock Market
- Equities
- METROPOLIS Stock
- Consensus Metropolis Healthcare Limited